Jain Global’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
Jain Global's MRNA Position: Q2 2026 in Review
Jain Global increased its Moderna (MRNA) stake by 189% in Q2 2026, buying an estimated $6.14M and bringing the position to 181,264 shares worth $12.7M. The position accounts for 0.05% of the portfolio, ranked #324.
Jain Global first reported a position in MRNA in Q4 2024 and has held it in 4 quarters since. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.
- Jain Global held 181,264 shares of Moderna worth $12.7M as of Q2 2026.
- Jain Global bought 118,618 Moderna shares in Q2 2026, an estimated $6.14M.
- Moderna made up 0.05% of Jain Global's portfolio in Q2 2026, its #324 holding.
- Jain Global first reported a position in Moderna in Q4 2024 and has held it in 4 quarters since.
- 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.
Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.